Bismuth subsalicylate
Sponsors
M.D. Anderson Cancer Center, Shanghai Jiao Tong University School of Medicine, Centers for Disease Control and Prevention, Bassett Healthcare, Fatih Sultan Mehmet Training and Research Hospital
Conditions
Antibiotic Resistant InfectionClostridium Difficile InfectionCure Rate of Helicobacter Pylori InfectionDiarrheaDiarrhea TravelersHealthy AdultsHelicobacter Pylori InfectionLymphoma
Phase 1
Phase 2
Phase 3
Phase 4
Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
CompletedNCT01742429
Start: 2012-11-30End: 2013-04-30Updated: 2014-08-29
Use of Bismuth Subsalicylate in Clostridium Difficile Colitis
WithdrawnNCT03592082
Start: 2018-03-01End: 2018-07-01Updated: 2018-07-19
THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY
CompletedNCT03757650
Start: 2018-10-01End: 2021-02-01Updated: 2021-03-23